The L76V mutation in HIV-1 protease is potentially associated with hypersusceptibility to protease inhibitors Atazanavir and Saquinavir: is there a clinical advantage?-Reference-Cited by-同舟云学术

The L76V mutation in HIV-1 protease is potentially associated with hypersusceptibility to protease inhibitors Atazanavir and Saquinavir: is there a clinical advantage?

Published:2011 Issue:1 Volume:8 Page:7
ISSN:1742-6405
Container-title:AIDS Research and Therapy
language:en
Short-container-title:AIDS Res Ther

Author:

Wiesmann Frank,Vachta Jan,Ehret Robert,Walter Hauke,Kaiser Rolf,Stürmer Martin,Tappe André,Däumer Martin,Berg Thomas,Naeth Gudrun,Braun Patrick,Knechten Heribert

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Virology,Molecular Medicine

Reference15 articles.

1. The Fitness Cost of Mutations Associated with Human Immunodeficiency Virus Type 1 Drug Resistance Is Modulated by Mutational Interactions

2. Fitness Comparison of Thymidine Analog Resistance Pathways in Human Immunodeficiency Virus Type 1

3. Molecular Determinants of Multi-nucleoside Analogue Resistance in HIV-1 Reverse Transcriptases Containing a Dipeptide Insertion in the Fingers Subdomain

4. Tenofovir Resistance and Resensitization

5. Prevalence of the HIV-1 protease mutation I47A in clinical practice and association with lopinavir resistance

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Non-active site mutants of HIV-1 protease influence resistance and sensitisation towards protease inhibitors;Retrovirology;2020-05-19

2. Characterizing Protein–Ligand Binding Using Atomistic Simulation and Machine Learning: Application to Drug Resistance in HIV-1 Protease;Journal of Chemical Theory and Computation;2019-12-26

3. Drug Resistance Mutation L76V Alters Nonpolar Interactions at the Flap–Core Interface of HIV-1 Protease;ACS Omega;2018-09-27

4. Drug Resistance Conferred by Mutations Outside the Active Site through Alterations in the Dynamic and Structural Ensemble of HIV-1 Protease;J AM CHEM SOC;2014

5. Prototypical Recombinant Multi-Protease-Inhibitor-Resistant Infectious Molecular Clones of Human Immunodeficiency Virus Type 1;Antimicrobial Agents and Chemotherapy;2013-09